Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients. - Wikidata - awgldk - TriplyDB

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

http://www.wikidata.org/entity/Q44561660

about

Nonmedicinal interventions in nonalcoholic fatty liver disease Non-alcoholic fatty liver disease: epidemiology, clinical course, investigation, and treatment.AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?Circulating fetuin-A levels are not affected by short and long-term energy deprivation and/or by leptin administration.The relationship between hepatic resistin overexpression and inflammation in patients with nonalcoholic steatohepatitis NLRP3 inflammasome activation is required for fibrosis development in NAFLD.The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease: A Strobe-Compliant Article.The Wide and Complex Field of NAFLD Biomarker Research: Trends.Recent advances in understanding the role of adipocytokines during non-alcoholic fatty liver disease pathogenesis and their link with hepatokines.Fetuin-A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects.Comparison of pre- and post-levothyroxine high-sensitivity c-reactive protein and fetuin-a levels in subclinical hypothyroidism.The Effect of Intraoperative N-Acetylcysteine on Hepatocellular Injury During Laparoscopic Bariatric Surgery. A Randomised Controlled Trial.The effects of HAP and macrophage cells to the expression of inflammatory factors and apoptosis in HK-2 cells of vitro co-cultured system.Changes in Bile Acid Profile After Laparoscopic Sleeve Gastrectomy are Associated with Improvements in Metabolic Profile and Fatty Liver Disease.Fetuin A is a Predictor of Liver Fat in Preoperative Patients with Nonalcoholic Fatty Liver Disease.Does bariatric surgery influence plasma levels of fetuin-A and leukocyte cell-derived chemotaxin-2 in patients with type 2 diabetes mellitus?

P2860

Q26992054-AB0255B4-289A-4C3C-BF44-44E029932D49 Q30434684-D72BCBEF-34E1-49E3-B07A-71F505A74DCC Q33688657-04D37999-4139-45A0-9AF2-D8D886E1D4D3 Q33883318-1CBBE1E6-50F7-4B91-8BA7-17D780DE6F3C Q35100100-77D77D71-344D-40B5-8F65-A09E6EDC9464 Q35146713-028937D4-9C2D-45A9-9BCF-2D5554D54262 Q35681974-DEB45702-FF8B-4600-8DE2-7041C6FAF28E Q36195780-D88B7B56-86FE-41EB-A072-E4E85041B2CD Q36962085-54B76777-DA71-4011-A928-43E93FBBDEC7 Q38665591-DEA06A80-6C8A-40D6-8972-DA15C131C29B Q38915869-106B7A5D-D2F8-4A84-A108-2DF930EFF8D7 Q43178306-C009185E-69F4-4790-B0F3-9F448FEA7C8B Q47646317-DC6B3037-10CB-4E42-A643-764E8F0F58A9 Q50148443-B55C2F1C-DB01-4D8D-ACB7-EBD5F6CDA19E Q51297557-BBFCFDC7-A259-4499-85F3-340303DB46E2 Q52854917-6518D7A9-AE48-4EB0-B205-FF0C8D5F04CB Q55339136-E10B810E-24F5-496E-AAB6-2174AB1B5792

P2860

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

http://www.wikidata.org/entity/Q44561660

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@en

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@nl

type

label

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@en

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@nl

prefLabel

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@en

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@nl

P1433

Q44561660-D5F25F08-DF92-4623-AFE1-0FF7708CCE66

P1476

Q44561660-0EA688AE-9591-49B1-9FDA-59831F5E18FB

P2093

Q44561660-1EEDD9D5-A9B6-4DCE-AE01-C88816D9A77A

Q44561660-224AB7FF-B1E8-42AB-82ED-DCA57797DC8B

Q44561660-3155918F-EAFD-47FD-A0DB-D96702CDD398

Q44561660-46AA8B3A-85D8-4D06-B88B-CB0B88725FB5

Q44561660-547A7F2A-743D-4DAC-83BF-48B9FF8397E3

Q44561660-5EDBCB5F-F04C-4789-932B-CD89F31A69AA

Q44561660-7BB6BCA8-4659-4540-A6D8-6247A44B961C

Q44561660-88050D1A-613C-4002-B1D2-701969F5552C

Q44561660-8A53A130-DD1E-4AA7-B729-151FC127DC5A

Q44561660-9685CEB9-AF75-4732-9ED3-F40395D020C2

P2860

Q44561660-006C9810-9B3B-4FE0-B02B-4AB7A8AF478E

Q44561660-0EAF7F05-F2FE-42A5-A0B0-3160DA121795

Q44561660-1286A946-3ABE-410A-9CA7-308AD2E574CE

Q44561660-275EB156-1528-44B6-9B9D-682068076784

Q44561660-276785CF-DCC0-4126-B001-758EF5ECC3E3

Q44561660-31299CA6-B84F-4E25-8966-A156A879A7F2

Q44561660-321B5AC2-396B-48E5-B06A-9CF059FCDA86

Q44561660-3F87F388-CCAB-45D8-9C74-82D26770744C

Q44561660-43B85BC2-305A-438E-AFD8-E2C611A5BFA6

Q44561660-4D0F5605-619C-4DBA-AEF7-11BB5D799FE8

P304

Q44561660-DA6352D8-83C0-4F56-82C8-B311FA8CD968

P31

Q44561660-241FB2F8-2B79-4002-A43D-FA1C1BA10CFE

P356

Q44561660-CA08F628-4CAC-4C54-8E2E-5D0FCD946D98

P407

Q44561660-28794654-850F-4BE9-9AF2-28CD89812F5B

P433

Q44561660-AE10D830-459C-4BAA-BC1A-9FC32ACAA908

P478

Q44561660-8382963F-15F9-42DD-BF21-0E641CAE763C

P50

Q44561660-08CD97E1-A3BB-4D29-BA67-3448569DBE98

P577

Q44561660-A3800355-238B-4B31-BBA1-9471DB97F260

P5875

Q44561660-D6D6E13F-3A25-4F46-AB53-9803D393E58C

P698

Q44561660-BA5EEDC3-8135-4298-BC2D-97B71E4E4222

P356

P1433

Clinical Science

P1476

Fetuin-A mRNA expression is elevated in NASH compared with NAFL patients.

@en

P2093

Akif Altinbaş

http://www.w3.org/2001/XMLSchema#string

Alexander Wree

http://www.w3.org/2001/XMLSchema#string

Ali Canbay

http://www.w3.org/2001/XMLSchema#string

Alisan Kahraman

http://www.w3.org/2001/XMLSchema#string

Alpaslan Kilicarslan

http://www.w3.org/2001/XMLSchema#string

Anja Beilfuss

http://www.w3.org/2001/XMLSchema#string

Jan-Peter Sowa

http://www.w3.org/2001/XMLSchema#string

Lars Peter Bechmann

http://www.w3.org/2001/XMLSchema#string

Martin Pronadl

http://www.w3.org/2001/XMLSchema#string

Martin Schlattjan

http://www.w3.org/2001/XMLSchema#string

P2860

Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study

Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.

Fetuin-A induces cytokine expression and suppresses adiponectin production.

The role of adipose tissue and adipokines in obesity-related inflammatory diseases

Comparison of electrophysiologic monitors with clinical assessment of level of sedation.

New clinical score to diagnose nonalcoholic steatohepatitis in obese patients.

Evaluation of Biomarkers of NAFLD in a Cohort of Morbidly Obese Patients.

Adipose and liver expression of interleukin (IL)-1 family members in morbid obesity and effects of weight loss

P304

391-400

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1042/CS20120542

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

125

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236579272

http://www.w3.org/2001/XMLSchema#string

P698

23627434

http://www.w3.org/2001/XMLSchema#string